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Enalapril decreases nuclear factor KB activation in the kidney
with ureteral obstruction
Rapid Communication
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Departments of Medicine and Cell Biology and Physiology, Washington University School of Medicine and Barnes-Jewish Hospita4
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Enalapril decreases nuclear factor KB activation in the kidney with
ureteral obstruction. The transcoption factor nuclear factor kappa B
(NF-KB) controls a number of genes associated with tissue inflammation
and has been shown to be activated in the kidney with ureteral obstruction.
In this investigation, we further explored NF-KB activation in the kidney
cortex of rats with unilateral ureteral obstruction. Electrophoretic mobility
shift assays combined with antibody supershift/depletion demonstrated
that NF-KB subunits p50, p52, c-rel, p65 (RelA) and ReIB were all
activated. Immunocytochemical analysis using an antibody to the p50
subunit demonstrated activation occurring predominantly in nuclei of
tubular cells. Treatment of animals with unilateral ureteral obstruction
with an oral ACE inhibitor significantly decreased NF-KB activation. This
suggests that the antiinflammatory effect of ACE inhibitors in renal
disease is in part due to a blunting of NF-KB activation.
A feature common to several renal diseases of diverse etiology
is the infiltration of the renal parenchyma by monocytes and other
blood-borne cells. These diseases include, but are not limited to,
aminonucleoside nephrosis [1], cyclosporine nephropathy [2],
hypercholesterolemia-induced glomerulosclerosis [3], obstructive
nephropathy [4], renal ischemia [5], albumin overload proteinuria
[6], adriamycin nephrosis [1 and diabetic nephropathy [8]. In
animals, experimental maneuvers such as the induction of essen-
tial fatty acid deficiency [9], x-ray irradiation [3, 10], and treatment
with probucol [11], angiotensin converting enzyme (ACE) inhib-
itors [12] or argininc in the drinking water [13, 14] reduce the
monocyte infiltration and ameliorate the progression of renal
disease during obstructive nephropathy.
Increased synthesis and expression of adhesion proteins and
chemoattractants in tissues contribute to monocyte infiltration of
such tissues [151. During ureteral obstruction there is an increase
in the expression of m000cyte chemoattractant protein 1 (MCP-
1), intracellular adhesion molecule 1 (ICAM-1) and vascular cell
adhesion molecule 1 (VCAM-1) [16, 17]. The activation of a
number of genes associated with tissue inflammation is controlled
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by the nuclear factor-kappa B (NF-KB) family of transcription
factors [18, 19]. The NF-kB subunit family members are desig-
nated PSO' p52, p65 (ReIA), c-Rd and Re1B, which are all
separate gene products [18, 19]. This family forms dimeric protein
complexes, is constitutively present in the cytoplasm of cells and,
upon activation, translocates to the nucleus to, in turn, activate
genes contributing to tissue inflammation [18, 19]. NF-KB has
previously been shown to be activated during experimental ure-
teral obstruction [20]. We have shown that ACE inhibition is
associated with a significant decrease in monocyte/macrophage
infiltration of the kidney with ureteral obstruction [12, 14].
Recently, ACE inhibition has also been shown to decrease
macrophage infiltration, MCP-1 expression and NF-KB activation
in the femoral artery of rabbits with experimental arteriosclerosis
[21]. This would be a possibility in our ureteral obstruction model
of chronic renal disease. In the present study we examined (I) the
activation of NF-KB, (2) the subunits involved, and (3) the effects
of oral administration of an ACE inhibitor on NF-KB activity in
the kidney of rats with unilateral ureteral obstruction (UUO).
METHODS
Animals and experimental protocols
Female Sprague-Dawley rats (Harlen Bioproducts, Indianapo-
lis, IN, USA) weighing 180 to 230 g were used in all experiments,
which employed protocols approved by the Animal Care Com-
mittee of the Barnes-Jewish Hospital of St. Louis. Most of the rats
underwent unilateral ureteral obstruction (UUO) as described
previously [12, 14]. Control rats, also referred to as normal rats,
underwent a sham operation [12, 14]. All animals were fed a
standard rat chow and given tap water or tap water containing 200
mg/liter enalapril (Sigma Chemical Co., St. Louis, MO, USA) ad
lihitum. ACE inhibitor administration was initiated 24 hours prior
to UUO and maintained throughout the period of UUO. Rats
were euthanized under pentobarhital anesthesia (5.0 mg/kg body
wt) given intraperitoneally after 4 or 120 hours of UUO. The
kidneys were perfused with ice-cold Hanks Balanced Salt Solution
(HBSS) until cleared of blood-borne cells.
Preparation of nuclear extracts
Kidney cortex was minced and disrupted in 10 volumes (about
1 ml) of 10 mtvt HEPES, pH 7.9, 10 m potassium chloride, 0.1
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mM EDTA, 0.1 mi EGTA, 0.1 msi DTT, and 1 ms phenylmeth-
ylsulfonyl fluoride by 6 strokes in a glass teflon homogenizer on
ice [221. Detergent Nonidet P-40 was added to a final concentra-
tion of 0.7% [221 and the homogenate centrifuged at 7,000 X g for
30 seconds. The pellet was suspended in fresh homogenization
buffer and recentrifuged at 7,000)< g for 30 seconds. The resulting
pellet was resuspended in 0.3 ml of 20 mivi HEPES, pH 7.9, 400
m sodium chloride, 1 mivi EDTA, 1 mrvi EGTA, 1 mcvi D11T and
1 mM phenylmethylsulfonyl fluoride. The resuspended pellet was
incubated on ice for 20 minutes with periodic pipetting and
centrifuged at 10,000 X g for 30 minutes. The supernatant was
removed, the protein content was determined by the Bradford
assay, and small amounts were frozen at —70°C.
Gel shift assays
The double-strand NF-KB consensus sequence 5'(AGTT-
GAGGGGACTVI'CCCAGG)3' was purchased from Promega
(Madison, WI, USA) and labeled with [32P] using T4 kinase
(Promega) and [32P] ATP (Amersham Corporation, Arlington
Heights, IL, USA). The binding of nuclear proteins to the
radiolabeled oligonucleotide was performed in a buffer of 10 mM
HEPES, pH 7.5, 100 m sodium chloride, 1 mM EDTA, 1 mM
DTT, 5% (vol/vol) glycerol and 2 j.tg/ml poly (dI/dC) [221. The
final volume of the reaction mixture was 10 s.d; it contained 5 jg
of nuclear protein extract and labeled oligonucleotide (100,000
cpm). After 15 minutes at room temperature (generally 21 to
23°C), the binding mixture was applied to a 22-cm long 6%
non-denaturing aciylamide gel in 0.5X Tris, borate, ethylenedia-
minetetraacetic acid buffer [22] and electrophoresed at 300 V for
about two hours. After drying the gel was subjected to radioau-
tography using Kodak BioMax film with an intensifying screen.
In some experiments, 1 l of concentrated antibody against the
p50, p52, p65, c-re! or Re1B subunits (Santa Cruz Biotechnology,
Santa Crux, CA, USA) was added to the binding reaction mixture
20 minutes or 14 hours prior to the addition of labeled o!igonu-
cleotide. For the 20 minutes of pretreatment with antibody the
nuclear extracts were incubated at room temperature. For the
14-hour pretreatment the extracts were incubated for 20 minutes
at room temperature, followed by 13 hours 20 minutes at 4°C and
finally for 20 minutes at room temperature prior to the addition of
labeled oligonucleotide. Regardless of the preincubation time, the
electrophoresis was performed for three hours to maximize the
separation of proteins and achieve some degree of resolution
between the migration of different homodimer and heterodimer
complexes that could hind to the labeled oligonucleotide. Conse-
quently, the unbound oligonucleotides migrated off the gel and
are not present on the autoradiograph replicas. As a control, an
antibody to the transcription factor c-fos (SC-52-G; Santa Cruz
Biotechnology) was added to the binding reaction mixture to
demonstrate the specfficity of binding of the NF-B subunit
antibodies.
Immunocytochemistry to localize the p50 subunit of NF-tcB
At the time of sacrifice, the kidneys were first perfused with
HBSS and then with cold Histochoice (Amresco, Solon, OH,
USA) [12, 14]. Two-millimeter coronal sections of each kidney
were dehydrated and placed in the same paraffin block and cut
into 4 p. sections. The deparaffinized and rehydrated sections were
treated with 3% hydrogen peroxide methanol (1:3) for 20 minutes
to inactivate endogenous peroxidase activity and then incubated
with I jkg/ml of polyclonal rabbit anti p50 antibody (Santa Cruz
Biotechnology) at 4°C overnight. The sections were washed in
HBSS, incubated with peroxidase-linked goat anti-rabbit IgG
(Sigma Chemical), washed, and visualized as described previously
[12, 14]. The slides were coded by a histologic core facility, so that
whoever viewed and photographed them would be blinded to the
experimental conditions represented.
RESULTS
As mentioned above, monocytes/macrophages infiltrate the
kidney cortex of rats with ureteral obstruction [12, 14]. The oral
administration of an ACE inhibitor decreases significantly the
number of monocytes/macrophages within the interstitium and
surrounding Bowman's capsule, leading to an apparent decrease
in the interstitial volume [14]. The studies we describe explore an
underlying mechanism(s) for this effect.
Nuclear extracts obtained from the kidney cortex were sub-
jected to electrophoretic mobility shift assay (EMSA) using a
[32P]-labeled oligonucleotide representing the NF-KB consensus
sequence (Fig. 1). The excess unbound oligonucleotide probe
migrated near the dye front on the autoradiograph replicas of the
gels. The nuclear extracts bound labeled oligonucleotides and
retarded their migration. The nuclear extracts obtained from the
kidney cortex of normal rats (Fig. 1A, lane 2) and from the
contralateral kidney of rats that underwent UUO (Fig. 1A, lane 3)
displayed a modest binding of labeled oligonucleotide in an area
of the gel designated region 1. The nuclear extract obtained from
the obstructed kidney bound more consensus sequence than
similar extracts from normal rat kidney in region 1 and had
significant binding in a second designated region of the gel (region
2; Fig. 1A, lane 4). Oligonucleotide binding in both regions of
extracts from the obstructed kidney could be chased by a 100-fold
excess of unlabeled consensus oligonucleotide (Fig. 1A, lane 5).
Both this study and a previous study [20] showed that NF-KB
activity was elevated in the kidney after five days of ureteral
obstruction. Infiltrating monocytes/macrophages could be a po-
tential source of the NF-KB since these cells are certainly present
in the renal parenchyma at five days after the onset of ureteral
obstruction [12, 14]. Therefore, we examined NF-KB activity in
the kidney cortex four hours after obstruction of the ureter. At
this time there is only a modest macrophage infiltration of the
renal parenchyma. Nuclear extracts obtained from the obstructed
kidney (Fig. IB, lane 4) bound considerably more NF-KB consen-
sus oligonucleotide than extracts from the contralateral (lane 3)
or the normal kidney (Fig. 1B, lane 2).
As mentioned above, the NF-KB transcription factors comprise
a family of proteins that bind to DNA as dimers [IS, 19].
Antibodies to individual proteins may be used in the binding
assays to supershift or to deplete homodimcric or heterodimeric
complexes that bind the radiolaheled oligonucleotides [23, 24].
We used such antibodies in two different protocols that yielded
similar results. The binding of labeled NF-KB consensus oligonu-
cleotide to region I did not display any sensitivity to preincuhation
of the extract with antibody (Fig. 2). The broad and apparently
diffuse binding of the labeled consensus oligonucleotide to the
nuclear extract obtained from the obstructed kidney in region 2
(Fig. 2A, lane 1) was probably the sum of binding to discrete
homodimer and heterodimer combinations of NF-KB subunits.
This extract had been preincubated with an antibody to c-fos prior
to electrophoresis, which provided an equal amount of antibody
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Fig. 1. Results of electrophoretic mobility shift assay for NF-iB activity,
showing binding of the NF-KB consensus sequence by nuclear extracts of
rat kidney cortex. The duration of ureteral obstruction was five days (A)
or four hours (B). Probe alone, lane 1. Nuclear extracts from: normal
kidney, lane 2; contralateral kidney of animals with one obstructed kidney,
lane 3; obstructed kidney, lane 4; obstructed kidney with a 100-fold excess
of unlabeled consensus sequence, lane 5. Results are representative of
findings in nuclear extracts obtained from three different animals for each
condition.
whether irrelevant or specific in each incubation. When the
extract was preincubated with individual antibodies that cause a
supershift (Fig. 2A, lane 2) for p50, or deplete binding (Fig. 2A,
lanes 3 to 6) for p52, c-rel, p65 or Rel B, respectively, well defined
bands of oligonucleotide binding remained. In reality, the de-
crease in label seen in region 2 when the extract was preincubated
with p50 antibody cannot be accounted for solely by the supershift
(Fig. 2A, lane 2); therefore, some depletion of binding occurred.
The basic pattern seen in Figure 2A was reproduced in three
experiments employing nuclear extracts of different animals.
There was no additional decrease in binding seen with antibody to
the p65 subunit (Fig. 2A, lane 5) when the amount of added
antibody was doubled or tripled (not shown) or when another
antibody to p65 (Santa Cruz Biotechnology SC-109X instead of
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Fig. 2. Results of electrophoretic mobility shift assay for NF-KB activity,
showing the effect of NF-KB subunit antibodies on the binding of the
NF-icB consensus sequence by nuclear extracts obtained from the cortex
of obstructed kidney (5 days) of rats. (A) Extracts were preincubated with
antibodies to c-fos (lane 1), p50 (lane 2), p52 (lane 3), c-rel (lane 4), p65(lane 5), or Re1B (lane 6). Lane 7 represents radiolabeled probe with no
added extract. (B) Nuclear extracts were preincubated with 5 J of c-fos
antibody (lane 1) or 1 1.d each of P50 p52, c-rel, p65 and ReIB antibody
(lane 2). Results are representative of duplicate experiments involving
20-minute or 14-hour pretreatments with antibody.
SC-372X) was used. In general NF-KB complexes containing
subunits p50, p52, c-rel or Re1B were more prevalent than
complexes containing p65 (Fig. 2A, lanes 2 to 6). Three bands of
NF-KB consensus oligonucleotide remained in region 2 after
antibody treatment that bound the consensus sequence. In other
experiments (Fig. 2B) the addition of all of the antibodies
together did not completely decrease NF-B consensus sequence
binding. In the experiments depicted in Figure 2B, the autoradio-
gram was exposed longer than in the experiments depicted in
Figure 2A. The nearly equivalent depletion of NF-KB binding
activity by antibodies in lanes 2, 3, 4 and 6 suggests that the
respective subunits are involved in NF-iB binding, but the studies
described may provide only a semiquantitative assessment of their
contribution.
Renal extracts from rats given the ACE inhibitor enalapril in
the drinking water also bound labeled NF-KB consensus oligonu-
cleotide. The extracts obtained from the contralateral kidney
cortex of animals given enalapril in the drinking water bound
more of the labeled consensus oligonucleotide (Fig. 3, lane 4) in
region 1 and 2 than similar extracts obtained from normal rats
drinking water alone (Fig. 3, lane 1). These extracts also displayed
modest binding in region 2 not seen in extracts obtained from
normal rats not given enalapril. Nuclear extracts obtained from
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Fig. 3. Results of electrophoretic mobility shift assay for NF-cB activity,
showing binding of NF-KB consensus sequence by nuclear extracts of rat
kidney cortex. Nuclear extracts represented are from the contralateral
kidney (lane 1) or the kidney with ureteral obstruction (lanes 2 and 3) of
untreated animals, and the contralateral kidney (lane 4) or the kidney with
ureteral obstruction (lanes 5 and 6) of animals treated with enalapril. A
100-fold molar excess of unlabeled consensus sequence was added to the
incubations represented in lanes 3 and 6. Results arc representative of
nuclear extracts obtained from three different animals for each condition.
the obstructed kidney cortex of animals given ACE inhibitor
bound significantly less NE-KB consensus oligonucleotide (Fig. 3,
lane 5) than extracts from the obstructed kidney of rats not given
enalapril (Fig. 3, lane 2) in both regions. As before, a 100-fold
molar excess of unlabeled consensus sequence totally displaced
the labeled oligonucleotide (Fig. 3, lanes 3 and 6).
Nuclear extracts prepared from kidneys of animals with UUO
for five days that had been treated with enalapril were preincu-
bated with antibodies to supershift or deplete NF-KB binding
activity (Fig. 4). In the EMSA of nuclear extracts obtained from
the contralateral kidney a diffuse hand of NF-KB binding activity
was present in the upper area of region 2 (Fig. 4A, lane 1) when
the autoradiogram was exposed longer than was the ease for
Figure 3. This diffuse area did not appear when the extract was
processed with an antibody to the p50 subunit of NF-KB (Fig. 4B,
lane 3). Antibodies to the known NF-KB subunits did not affect
NF-KB consensus sequence binding in other regions in the EMSA
of extracts of the eontralateral kidney (Fig. 4B). In the EMSA of
nuclear extracts obtained from the obstructed kidney of animals
with UUO that were treated with enalapril, only the antibody to
the p50 subunit caused a supershift (Fig. 4B, lane 10) of binding
activity in region 2. There was no significant diminution of NF-KB
consensus sequence binding by other antibodies in region I or
region 2 (Fig. 4B, compare lane 9 to lanes 11 to 14). This is
significantly different from the effects of the antibodies on NF-KB
binding activity in the untreated animal (Fig. 2).
To determine the cell type(s) in which NF-KB activation was
occurring, we performed immunocytochemical analysis using an
antibody to the p50 subunit. Kidneys of normal rats had occa-
sional tubular and interstitial cell nuclei within the cortex that
were positive for p50 (Fig. 5A). In the kidney with ureteral
obstruction, numerous nuclei were positive for p50 (Fig. 5B). The
most prevalent and most intensely staining cells reacting with the
p50 subunit antibody were tubular cells; however, interstitial cells
were also positive after five days of IJUO. In sections of the
contralateral kidney of rats treated with an ACE inhibitor there
were many more positive cell nuclei (Fig. SC) than were found in
the kidney of untreated animals (Fig. SA). An occasional glomer-
ular cell nucleus was also positive for p50. In the obstructed
kidney of animals that underwent UUO and were treated with the
ACE inhibitor, there were fewer tubular cell nuclei (Fig. SD) than
were found in the obstructed kidney of animals with untreated
UUO (Fig. SB). The interstitial volume of the obstructed kidneys
of animals treated with enalapril was considerably less than that of
the obstructed kidney from untreated animals (compare Fig. SB
and SD), as we have found previously [17]. With fewer interstitial
cells there were fewer cells in the interstitium that reacted with
the NF-KB p50 subunit antibody.
DISCUSSION
We found an increase in NF-KB expression in the obstructed
kidney of rats with unilateral ureteral obstruction, confirming the
observation of Wendt et al [201. Furthermore, we have extended
this initial observation [20] and characterized the type(s) of
NF-KB subunits that are activated and the cell type(s) of the kidney
in which this activation occurs. Our results suggest that the antiin-
flammatory effect of ACE inhibitor administration in the kidney of
rats with ureteral obstruction may be due to decreased activation
of NF-KB. Enalapril administration significantly decreased the
ability of proteins extracted from the nucleus to hind to an NF-KB
consensus oligonucleotide compared to similar extracts obtained
from the kidneys of untreated animals. This is similar to findings
in the rabbit model of atherosclerosis in the femoral arteries [21].
Furthermore, these studies have uncovered nuclear proteins that
bind to the NF-KB consensus oligonucleotide that are not recog-
nized by any of the current NF-KB subunit antibodies.
A possible factor contributing to the marked increase in NF-KB
activity within the nuclei isolated from the obstructed kidney is the
infiltrating monocytes/macrophages. Undoubtedly these cells may
account for some of the transcription factor activity in the
obstructed kidney of animals not given ACE inhibitor. A decrease
of these infiltrating cells in the obstructed kidney of animals given
ACE inhibitor probably contributes to the decrease in NF-KB
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Fig. 4. Results of electrophoretic mobility shift assay for NF-KB activity, showing the effect of NF-KB subunit antibodies on the binding of the NF.icB
consensus sequence by nuclear extracts from the cortex of contralateral and obstructed kidney (5 days) of rats with UUO treated with enalapril. (A)
Extracts processed without antibody: lane 1, contralateral; lane 2, obstructed. (B) Extracts processed with antibody: lanes 2 to 7, contralateral; lanes 9
to 14, obstructed. No extract, probe alone: lanes 1 and 8. Extracts were preincubated with antibodies to c-fos (lanes 2 and 9), p50 (lanes 3 and 10), p52(lanes 4 and 11), c-rel (lanes 5 and 12), p65 (lanes 6 and 13), or Rd B (lanes 7 and 14).
transcription factor activity in the nuclei. However, enalapril
treatment probably does not account for the bulk of the observed
change in NF-KB activity in the kidney with ureteral obstruction.
Localization of the p50 subunit of NF-KB by immunocytochemical
analysis indicates that the bulk of the labeled nuclei were found in
tubular cells. Also, there is an increase in NF-KB activity present
in the obstructed kidney of rats with UUO in as little as four
hours. There were no demonstrable changes in the number of
monocytes/macrophage in these kidneys at this time interval [141.
All these factors suggest that tubular cells of the kidney are a
source of the NF-KB binding activity.
Another possible contributor to the massive increase in NF-KB
activity within nuclei isolated from kidneys with ureteral obstruc-
tion is the proliferation of interstitial fibroblasts. Fibroblasts
proliferate and contribute to the increase in interstitial volume
[12, 14] and eventually the development of fibrosis [12, 14]. These
fibroblasts differentiate into myofibroblasts [14, 251 as indicated by
the expression of alpha smooth muscle actin [14, 26]. ACE
inhibitor administration inhibits fibroblast proliferation and alpha
smooth muscle actin expression [141. If the flbroblasts do not
proliferate during enalapril administration, then there are likely
no other cells in the interstitium that express the alpha smooth
muscle actin or that contain NF-KB.
The third and most likely source of the NF-KB activity in the
kidney of rats with ureteral obstruction is the intrinsic tubular and
glomerular cells. This possibility is considerably strengthened by
the observation that NF-KB activity was up-regulated predomi-
nantly in the nuclei of tubular cells following obstruction of the
ureter. This dampening effect of ACE inhibitor on NF-KB up-
regulation in the kidney with the obstructed ureter persisted for
the five days of UUO examined in this study. Interestingly, there
was a consistent increase in the NF-KB consensus sequence
binding activity seen in region 2 of the contralateral kidney (Figs.
3 and 4) and in p50 subunit antibody localization in the nuclei of
intrinsic tubular and glomerular cells (Fig. 5C). Angiotensin
converting enzyme, which converts angiotensin Ito angiotensin II,
is a kininase that degrades bradykinin and substance P [27].
Bradykinin can stimulate NF-KB activation in cultured fibroblasts
[28] but whether it can do so in kidney cells is not known. An
interesting observation associated with the ability of ACE inhibi-
tion to ablate an inflammatory response by blunting NF-KB
activation is that NF-KB p50 homodimers remain activated in the
obstructed kidney or become activated in the contralateral kidney
(Fig. 4B). The p50 subunit does not contain a transactivation
domain and is therefore tantamount to a transcription repressor
[18, 19]. Whether blunting the activation of transcriptional en-
hancers while maintaining transcriptional inhibitors is a general
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Fig. 5. Immunocytochemical localization of the
p50 subunit of NF-icB in the kidney cortex.
Kidney sections were obtained from the
contralateral unobstructed kidney (A and C) or
the kidney with ureteral obstruction (B and D)
of untreated (A and B) or enalapril-treated (C
and D) animals. The p50 subunit was found to
be located within the nuclei of the cells. The
duration of UUO was five days. Results are
representative of three different animals at each
condition tested.
feature of the effect of ACE inhibition on inflammation remains
to be determined.
Two major questions about NF-xB activity in UUO remain.
First, what is the possible mechanism by which oral ACE inhibitor
administration decreases nuclear NF-scB location? Enalapril in
the drinking water increases nitrite excretion [14], which is an
indicator of nitric oxide generation. Nitric oxide has been shown
to inhibit NF-g13 activation in endothelial cells in culture [22, 29].
Two other possible mechanisms yet to he explored are the effects
of ACE inhibition on (I) the phosphorylation and (2) the
proteolysis of inhibitory xB proteins that retain the NF-xB
subunits in the cytoplasm [18, 19]. The second question raised by
the present study is: what is the nature of the proteins that bind to
the NF-icB oligonucleotides but are not recognized by antibodies
to the known NF-cB subunits, particularly in the contralateral
kidney of ACE inhibitor treated animals? The members of the
NF-KB family can interact with other transcription factors. These
include high mobility group 1(Y) [30], nuclear faetor-1L6 [31],
retinoblastoma gene product [32], all-transretinnic acid sensitive
proteins [33], interferon y-induced proteins [34] and CBP/p300
[35]. It is not known whether the association of NF-icB with any of
these proteins masks antibody interaction. Recently, another
protein unrelated to the NF-KB family has been described that
binds to and regulates the KB site in the interleukin 2 receptor a
gene promoter [36]. The ability of ACE inhibitors to affect any of
these factors remains to he determined.
In summary, this investigation demonstrates that significant
NF-,cB activation occurs in the experimental kidney of rats that
have undergone UUO. Oral ACE inhibitor administration blunts
the activation of NF-,cB in the obstructed kidney. Oral ACE
932 Morrissey and Klahr: Enalapril decreases A/F- KB in the kidney
Fig. S. Continued.
inhibitor administration also modulates the activity of proteins
that bind to the NF-KB oligonucleotide sequence in the contralat-
eral kidney. The effect of oral enalapril on nuclear NF-KB activity
may contribute, in part, to the antiinflammatory effect of this
treatment.
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APPENDIX
Abbreviations used in this paper are: NF-KB, nuclear factor KB; ACE,
angiotensin converting enzyme; MCP-1, monocyte chemattractant protein
1; ICAM-i, intracellular adhesion molecule 1; VCAM-l, vascular cell
adhesion molecule 1; UUO, unilateral ureteral obstruction; 1-TBSS, Hank's
balanced salt solution; EMSA, electrophoretic mobility shift assay.
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